Earlier this week, the nation's top infectious disease expert, Anthony S. Fauci, announced that trial data showed the antiviral drug remdesivir had a "clear-cut, significant, positive effect in diminishing the time to recovery." The FDA's action allows health-care providers to administer remdesivir intravenously to treat covid-19 in adults and children hospitalized with severe symptoms. |
No comments:
Post a Comment